ASPN and congenital bilateral aplasia of vas deferens from CFTR mutation: Therefore, studies on the regulatory mechanism between Asporin and Wnt/β-catenin signaling in the valvular mineralization process might be worth exploring in the purview of CAVD therapeutics.